Skip to main content
Premium Trial:

Request an Annual Quote

Thermo Fisher Eliminates 315 Jobs, Records $18.2M in Charges

NEW YORK (GenomeWeb News) – Thermo Fisher Scientific took charges of $18.2 million during the first quarter associated with a reduction in headcount of about 315 employees, the company said in its Form 10-Q this week.

The charges are cash costs related to headcount reductions and facility consolidations and consisted of severance to the employees who were laid off. It is unclear whether all 315 layoffs occurred in the first quarter ended March 31, however.

The company took $7.9 million in cash costs in its Analytical Technologies segment related to the layoffs of about 170 employees, it said in its document filed with the US Securities and Exchange Commission.

In Specialty Diagnostics, cash costs amounted to $6.5 million in severance for approximately 75 employees, and in Laboratory Products and Services, Thermo Fisher recorded cash costs of $3.8 million in severance for about 70 employees.

In 2012, the company eliminated about 1,120 jobs. Thermo Fisher currently plans to buy Life Technologies for about $13.6 billion.

The Scan

Open Pediatric Brain Tumor Atlas Team Introduces Genomic Data Collection, Analytical Tools

A study in Cell Genomics outlines open-source methods being used to analyze and translate whole-genome, exome, and RNA sequence data from the Pediatric Brain Tumor Atlas.

Neurological Outcomes Linked to Innate Immune Features After Cardiac Arrest

Researchers reporting in Med dig into immune features found a few hours after cardiac arrest that correspond with neurological outcomes.

Mouse Study Finds Circadian Rhythm-Related Gene Expression Changes Linked to Sleep Apnea

A paper in PLOS Biology reveals tissue-specific circadian rhythm and gene expression patterns in an intermittent hypoxia-based mouse model of obstructive sleep apnea.

Polygenic Risk Score to Predict Preeclampsia, Gestational Hypertension in Pregnant Women

Researchers in Nature Medicine provide new mechanistic insights into the development of hypertensive disorders of pregnancy, which may help develop therapeutics.